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LABORATORY INVESTIGATION
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Removal of subepithelial immune complexes with excess unaltered or
cationic antigen. Since cationic molecules are known to pass through the
lamina densa of the glomerular basement membrane at higher rates than
anionic molecules, the ability of cationic antigen to disperse subepithe-
hal glomerular immune deposits was investigated in rats. Subepithelial
glomerular immune deposits were formed in rats by the sequential
administration of cationized human serum albumin (HSAED) and puri-
fied rabbit antibodies to human serum albumin (HSA). In vitro the
addition of fiftyfold excess HSA or HSAED to immune precipitates
formed with HSAED and antibodies to human serum albumin (antiHSA)
solubilized the precipitates to comparable degree. Excess HSA or
HSAED was given intravenously to rats which already had HSAED-
antiHSA immune deposits in glomeruli. Serial renal biopsies were
obtained and examined. Control animals received saline or nonspecific
cationic molecules, protamine sulfate or cationized rabbit serum albu-
min, without any effect on the persistence of immune deposits in
glomeruli. The injection of 10 mg of HSAED caused complete disap-
pearance of glomerular immune deposits by 48 hours. In contrast, 100
mg of HSA was required to achieve the same effect. Thus, cationic
antigens are more efficient than anionic antigens in the removal of
subepithelial glomerular immune deposits.
Since the discovery of fixed negative charges in the glomer-
ular capillary basement membrane [1—4], several studies have
shown that sequential administration of a cationic antigen of an
appropriate size and corresponding antibodies lead to formation
of subepithelial immune deposits in the glomerular capillary
basement membrane [5—7]. The same results were obtained
when cationic antibodies were administered first and followed
by the specific antigen [8]. Furthermore, the formation of
electron dense deposits and persistence of these immune de-
posits in the subepithelial area required precipitating antigen—
antibody systems [9, 101.
The mechanisms by which macromolecules and specifically
immune complexes localized in the glomeruli are removed have
been examined by several approaches. Elema, Hoyer and
Vernier [11] showed that intravenously injected colloidal car-
bon is taken up by the glomerular mesangium in rats and
ultimately transported to the stalk area. By using Chediak—
Higashi mice, Striker, Mannik and Tung [12] showed that
marrow—derived monocytes contribute to the clearance of
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immune complexes from the mesangial area. The subepithelial
immune deposits in glomeruli are not accessible to circulating
phagocytic cells. In one model system the half—life of these
deposits in rats was 12 days [7]. The mechanism for the slow
disposal of the subepithelial deposits remains unknown. Other
approaches to enhance the understanding of formation and
removal of glomerular immune deposits have included the
removal of immune deposits with excess antigen or by admin-
istration of nonspecific cationic molecules. Mannik and Striker
[13] showed that glomerular mesangial immune deposits in mice
were dispersed by the administration of excess antigen in less
than 12 hours. The application of this approach to a chronic
serum sickness model in mice showed that the excess intrave-
nous antigen dissolved glomerular immune deposits early in the
course of the disease, but after four weeks of the disease this
became less effective [14]. In addition, the administration of
competing, nonspecific cationic molecules along with the
cationic antigen in chronic serum sickness model was found to
result in decreased glomerular immune deposits in rabbits [15].
The present investigation was undertaken to compare the
ability of native human serum albumin and cationized human
serum albumin to dissolve subepithelial immune deposits in rat
glomeruli.
Methods
Preparation of antigens and antibodies
Monomeric human serum—albumin (HSA) (Miles/Pentex,
Kankakee, Illinois, USA) and monomeric rabbit serum albumin
(RbSA) (Sigma Chem. Co., St. Louis, Missouri, USA) were
obtained by DEAE ion—exchange chromatography, and gel
filtration on Sephacryl S-200 (Pharmacia Fine Chemicals,
Pistacataway, New Jersey, USA). Antibodies to HSA were
raised in rabbits, purified by affinity chromatography, as previ-
ously described [16], and monomeric antibodies obtained by gel
filtration on Sephadex G200 (Pharmacia Fine Chemicals).
HSA and RbSA were cationized as previously described [17],
with some modifications. The albumin solution was dialyzed
into 0.1 M sodium acetate buffer pH 4.7. Ethylene diamine (ED)
8.41 pi/mg protein was added to a flask containing 25 ml of 0.1
M sodium acetate buffer and the pH adjusted to 4.7 with HCI.
The protein solution was then rapidly added to the reaction
vessel with constant stirring. l-Ethyl-3 (3 diamethylamino-
propyl) carbodimide HCI (4.80 smg protein) was then added
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 14 Agodoa and Mannikand the pH adjusted to and kept at 4.7 at 4°C, with constantstirring, for 30 minutes. The reaction product was then dialyzed
against 0.2 M sodium borate, 0.15 M NaC1 pH 8.0 buffer for 48
hours.
Radioiodination of antibodies to HSA with 1251 was carried
out by Lhe io'line monochloride methods [18], yielding specific
activity of approximately 2.5 pCilmg protein.
Solubilization of immune precipitates in vitro
Immune precipitates were made with either 30 g of HSA or
30 jg HSAED and 200 ,g 125J antiHSA. The chosen values
represented the point of maximum precipitate formation. The
immune precipitates were centrifuged at room temperature at
3000 rpm for 15 minutes, and the supernatant decanted. Antigen
at fiftyfold excess in borate buffer was then added to each
precipitate, thoroughly mixed, and incubated either at room
temperature (25°C) or at 37°C for 24 hours. For buffer control,
an equal volume of 0.2 M borate buffer, pH 8.0 was added to
tubes containing immune precipitates and incubation carried
out at the respective temperatures for 24 hours. The tubes were
then centrifuged at room temperature at 3000 rpm for 15
minutes. The supernatants were separated, and the amount of
1251 antiHSA present in the supernatant and the residual im-
mune precipitates determined using a gamma counter. The
percent solubilization was then calculated.
Animal experiments
Sprague—Dawley rats weighing 350 to 400 g were used. The
animals were anesthetized with 0.2 ml of 1:5 dilution of
Inovar—Vet® (McNeil Laboratories, Inc., Fort Washington,
Pennsylvania, USA). A midline abdominal incision was made,
the left renal artery dissected out and canulated with 25-gauge
needle and 300 j.g of HSAED in 500 /Ll of 0.2 M borate buffer pH
8.0 infused. Blood flow was then immediately restored to the
kidney, with total ischemia time of approximately two minutes.
One hour later, 1.0 mg of antiHSA was administered intrave-
nously for in situ subepithelial immune deposit formation, as
previously described [91. Four hours later, antigen excess of
either HSA or HSAED was administered intravenously in a total
of 2 ml volume of 0.2 M borate buffer over a five minute period.
Control animals received 2 ml of 0.2 M borate buffer. To control
for nonspecific effect due to charge alteration, 10 mg of cation-
ized rabbit serum albumin (RbSAED) in 2.0 ml volume, or 1 to
10 mg of Protamine sulphate (Eli Lilly Co., Indianapolis,
Indiana, USA) was given to some animals with subepithelial
immune deposits.
Sequential renal biopsies were obtained at designated time
points by open renal biopsy under anesthesia. There were five
to seven rats analyzed for each time point. The tissues were
then divided and immediately processed for immunofluores-
cence and electron microscopy.
For immunofluorescence microscopy, the tissue was embed-
ded in Tissue Tek II O.C.T. Compound (Ames Co., Elkart,
Indiana, USA), quick frozen with dry ice and stored at —20°C
until further studied. Six m sections were cut, washed and
stained with specific fluorescenated antibodies to HSA, rabbit
IgG, and rat C3, as previously described [19]. At least 20
glomeruli were examined in each specimen.
Tissues for electron microscopy were fixed in gluteraldehyde
buffered with sodium cacodylate. They were then post-fixed in
Fig. 1. Isoelectric focusing patterns of human serum albumin (HSA)
and rabbit serum albumin (RbSA) preparations. Lane (a) shows the
standards, Lane (b), unaltered HSA. In Lane (c) HSAED focuses in the
p1 range of> 8.15, while Lane (e) shows RbSAED focusing predomi-
nantly in the p1 range > 9.0. Lane (d) shows unaltered RbSA.
1% buffered osmium tetraoxide and embedded in epoxy resin.
Thin sections were cut on the LKB III Ultratome, stained for
two hours with uranyl acetate, then lead citrate for five minutes.
The sections were then examined with transmission electron
microscope (Type 801 AEI Scientific Apparatus Division,
Harlow, Essex, UK). At least eight glomeruli were examined in
each specimen.
Results
Characterization of antigen preparations
By isoelectric focusing the cationized HSA and RbSA fo-
cused in the p1 range of 8.5 to 10.0 (Fig. 1). There was no
significant difference in the degree of cationization between the
RbSAED and the HSAED.
Solubilization of immune precipitates in vitro
Prior to proceeding with animal experiments, studies were
done to compare the ability of native and cationic HSA to
solubilize immune precipitates made with antibodies to HSA
and native HSA or cationic HSA. When the immune precipi-
tates were prepared with native HSA, the addition of fiftyfold
excess HSA solubilized the precipitates much better than
HSAED (see Table 1). This occurs most likely due to loss of
antigenic determinants on HSA by cationization. In contrast,
when the immune precipitates were prepared with HSAED, then
a b C
9.30 —
8.65 —
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Removal of subepithelial immune deposits 15
Table 1. In vitro solubilization of immune precipitates
with fifty-fold excess antigen
.
Ag in immune
precipitate
.. .
Solubilizing
agent
% Solubilization at
25°C 37°C
HSA HSA 70.7 92.2
HSA HSAED 13.4 15.8
HSA BBS buffer 5.1 8.1
HSAED HSA 59.4 66.2
HSAED HSAED 68.2 73.8
HSAED BBS buffer 14.4 18.7
BBS consists of 0.2 M sodium borate, 0.15 M sodium chloride buffer
pH 8.0.
the solubilization of the immune precipitates by fiftyfold excess
HSA and HSAED were comparable (see Table 1). These results
clearly indicated that immune deposits formed in vivo with
HSAED should be solubilized equally well by excess HSA and
HSAED provided these antigens had equal access to the immune
deposits. Furthermore, the addition of RbSAED or protamine
sulfate in borate buffer to the immune precipitates did not
solubilize the immune precipitates (data not shown).
Solubilization of subepithelial immune deposits with excess
antigen
Immediately prior to administration of excess antigen,
RbSAED or protamine sulfate, all tissues obtained from the left
kidney revealed the presence of rabbit IgG in all glomeruli at 4+
level (Table 2). No significant difference was seen at four hours
after the administration of excess antigen, HSA or HSAED, at
the employed dosages. By 24 hours after excess antigen admin-
istration, there was no significant reduction in the presence of
rabbit IgG in the glomeruli with 5 mg or 10 mg HSA (Fig. 2). On
the other hand, 100 mg HSA showed moderate reduction, equal
to reduction produced by 5 mg HSAED. Ten mg HSAED was
even more effective in reducing the presence of rabbit IgG in
glomeruli. By 48 hours, only trace amounts of rabbit IgG was
detectable in the glomeruli of rats that received 100mg HSA,
and negative in those that received 10 mg HSAED. No further
reduction was seen in the animals that received 5 and 10 mg
HSA. The rats that received 5 and 10 mg R1DSAED and 1 and 10
mg protamine sulfate after the in situ immune deposit formation
in the glomeruli show no significant dissolution of the deposits,
as compared to those given buffer alone.
Examination by transmission electron microscopy revealed
the presence of subepithelial electron dense deposits prior to
the administration of excess antigen. These deposits are mark-
edly diminished in number by 24 hours in the glomeruli of the
rats that received 10 mg HSAED, and no detectable electron
dense deposits were seen in this group of animals by 96 hours
(Fig. 3). The animals that received 100 mg excess HSA showed
similar findings. On the other hand, the animals that received
excess 10 mg HSA showed no significant difference in the
presence of electron dense deposits from control animals.
Discussion
The presented data showed that the immune precipitates
formed with cationic HSA and rabbit antibodies to HSA were
solubilized in the test tube to comparable extent by native and
cationized HSA. The addition of new amino groups to HSA
changes several of its properties. Purtell et al [20] showed that
cationization of HSA by the used method reduced the stokes
radius of HSA from 35A to 33A. They further showed that the
clearance from plasma was directly related to the degree of
charge alteration of the molecule. By our own observations,
cationization of HSA reduced the effectiveness of its binding to
antiHSA (data not shown). Precipitin curves, with radiolabeled
HSA and HSAED gave parallel lines, but the maximum precip-
itation of HSAED in antibody excess was less than that of
monomeric HSA (45% vs. 80%, respectively). These findings
indicate that by cationization not all antigenic determinants of
the HSA are retained. The important point, however, is that in
the test tube HSA and HSAED solubilized immune precipitates
prepared with HSAED to comparable degree, thus allowing the
testing of the hypothesis that a cationic antigen will solubilize
subepithelial glomerular immune—deposits better than an an-
ionic antigen owing to enhanced access to this site. One,
however, must also consider the size of the cationic molecules
since cationic substances of the size of the 1gM do not penetrate
the lamina densa [21].
Several studies have shown that the administration of
cationic antigens to experimental animals, followed by injection
of specific antibodies, cause the formation of subepithelial
immune deposits [5—7]. These deposits are characteristically
localized at the slit pore membrane, similar to the deposits seen
in human membranous glomerulonephritis. In contrast, the
cationic antigens alone initially decorate primarily the fixed
negative sites in the lamina rarae interna and externa. The
immune deposits at the slit pore membrane form and persist in
glomeruli only when a precipitating antigen—antibody system is
employed [9]. The same study also showed that nonprecipitat-
ing antigen—antibody systems, which are known to form only
small—latticed immune complexes, neither result in immune
deposits that persist in glomeruli nor in immune deposits at the
slit pore membrane. Therefore, if already—formed immune
deposits at the slit pore membrane were converted to small—lat-
ticed immune deposits by excess antigen, these small—latticed
complexes should disappear from glomeruli. The presented
data show that indeed excess HSA and cationic HSA both
cause disappearance of subepithelial immune deposits. Tenfold
more HSA than HSAED, however, was required to achieve
complete dispersion of the HSA-antiHSA immune deposits in
the subepithelial area. Of note is that a smaller nonspecific—
cationic molecule, protamine sulfate, and cationized rabbit—
serum albumin had no effect on the subepithelial deposits.
These results exclude the possibility of displacement of the
formed deposits owing to disruption of charge—charge interac-
tions.
High degrees of antigen excess in the HSA-antiHSA system
results in the formation of small—latticed immune complexes
(Ag1 Ab1 or Ag2 Ab2) [22]. Previous studies have shown that the
administration to mice of small—latticed immune complexes
does not result in glomerular immune deposits [23]. Further-
more, small—latticed immune complexes with cationized anti-
bodies initially bound to glomerular structures but did not
persist [24]. The enhanced removal of subepithelial immune
deposits by cationic HSA as compared to native HSA is most
likely caused by the enhanced passage of these molecules
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Table 2. Glomerular presence of rabbit IgG in immune deposits after administration of excess antigen,
protamine sulfate, or cationized rabbit serum albumina
Protamine
.Time of
biopsy
Buffer
control
HSA HSAED
5 mg 10 mg 5 mg
RbSAED
10 mg I mg
sulfate
10 mg5 mg 10 mg 100 mg
0b 4+ 4+ 3.5+ 4+ 3.5+ 4+ 4+ 4+ 4+ 3.5
4hrs 4+ 3.5+ 3+ 3.5+ 3+ 3.5+ ND ND ND 3+
l2hrs ND ND ND 2+ ND 2+ ND ND ND 3.5+
24hrs 3.5+ 3+ 2,5+ 2+ 2+ 1+ 3+ 3+ 3+ 3+
48hrs 3,5+ 2.5+ 2+ 1+ 0 3+ 3.5+ 3.5+ 3+
96hrs 3+ 2.5+ 2.5+ 0 0 3.5+ 3+ 3+ 3.5+
a Five to seven rats were analyzed for each time point. Tissues were stained with fluorescenated—goat anti-rabbit IgG.
b Biopsy obtained prior to administration of excess antigen
' ND, not done
None HSA1Om9 HSAfl1Omg
Time of
biopsy
0 (Pre)
24 hrs
96 hrs
Fig. 2. Photomicrographs of glomerular immunofluorescence after staining with fluorescenated antibodies to rabbit IgG before and after the
administration of excess antigen. Prior to the administration of excess antigen (0, Pre), all three groups showed strongly positive staining for rabbit
IgG. Twenty—four hours after the administration of 10mg of excess antigen, HSA induced mild reduction in glomerular immune deposits, whereas
HSAED caused marked reduction in deposits. By 96 hours, no further reduction was seen with this dose of HSA, whereas glomeruli from animals
that received excess HSAED showed complete absence of immune deposits.
through the lamina densa, thus leading to a high local its, formed by solubilization of immune deposits with excess
antigen—excess. The increased passage of molecules through antigen, are removed from the subepithelial area remains to be
the lamina densa in the absence of the usual charge barrier is elucidated.
well documented. Alder et al [15] reported that protamine sulfate administration
The mechanism by which the small—latticed immune depos- to rabbits with chronic serum sickness resulted in decreased
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Fig. 3. Electron photomicrographs of glomeruli in rats
96 hours after the administration of 10 mg of excess
HSAED (B) and before injection of excess antigen (A).
Before excess HSAED electron dense deposits (arrow
heads) are present in the subepithelial space, primarily
at the slit pores. After excess HSAED, no such deposits
are present. Abbreviations are: CL, capillary lumen;
EC, endothelial cell; EpC, epithelial cell; GBM,
glomerular capillary basement membrane; US, urinary
space; A and B >< 20,000.
immune deposits in glomeruli. In their experiments some of binding of the chronically administered, cationic bovine serum
the protamine sulfate was administered concurrent with the albumin.
antigen and may have mediated the decrease in gb- If excess antigen administration will ever achieve clinical
merular deposits mainly by interfering with glomerular application for dissolution of glomerular immune deposits, then
18 Agodoa and Mannik
appropriate cationic antigens should be considered for use in
membranous glomerulonephritis.
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